CD44 and breast cancer: Recently, we have shown the novel tGLI1 isoform to promote the glioma stem cell population via upregulation of CD44 and the breast cancer stem cell population through upregulation of CD44, Nanog, OCT4, and Sox2 (Section 6) [31,33].